| 英文名称 |
中文名称 |
CAS号 |
操作 |
| CHIR-090 |
CHIR 090 |
728865-23-4 |
详细
|
| MS023 |
N1-甲基-N1-[[4-[4-(异丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺 |
1831110-54-3 |
详细
|
| Vipadenant(BIIB-014) |
3-(4-氨基-3-甲基苄基)-7-(呋喃-2-基)-3H-[1,2,3]三唑并[4,5-d]嘧啶-5-胺 |
442908-10-3 |
详细
|
| VLX600 |
VLX600 |
1622945-04-3 |
详细
|
| FEN1 Inhibitor C3 |
3-羟基-1-(4-甲氧基苯基)喹唑啉-2,4(1H,3H)-二酮 |
2109805-87-8 |
详细
|
| FEN1 Inhibitor C2 |
FEN1 Inhibitor C2 |
1995893-58-7 |
详细
|
| SGC2085 |
SGC2085 |
1821908-48-8 |
详细
|
| LY-3381916 |
LY-3381916 |
2166616-75-5 |
详细
|
| AZD 7648 |
AZD-7648 |
2230820-11-6 |
详细
|
| CPI-444 |
CPI-444 |
1202402-40-1 |
详细
|
| E-7046 |
E-7046 |
1369489-71-3 |
详细
|
| LY2886721 HCl |
N-[3-[(4AS,7AS)-2-氨基-5,7-二氢-4H-呋喃并[3,4-D][1,3]噻嗪-7A(4AH)-基]-4-氟苯基]-5-氟-2-吡啶甲酰胺盐酸盐 |
1262036-49-6 |
详细
|
| ACH-4471 |
Danicopan |
1903768-17-1 |
详细
|
| NTP-42 |
NTP-42 |
2055599-51-2 |
详细
|
| Pixantrone maleate |
马来到匹杉琼 |
144675-97-8 |
详细
|
| KD025 (SLx-2119) |
2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-异丙基乙酰胺 |
911417-87-3 |
详细
|
| TD-4208 |
雷芬那辛 |
864750-70-9 |
详细
|
| JNJ26854165 2HCl |
Quisinostat 二盐酸盐 |
875320-31-3 |
详细
|
| Fumagillol |
烟曲霉醇 |
108102-51-8 |
详细
|
| C75 |
反-4-羧基-5-辛基-3-甲基-丁内酯 |
191282-48-1 |
详细
|
| SD-06-1 |
3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑 |
271576-80-8 |
详细
|
| ON123300 |
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
详细
|
| PD0166285 |
6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 |
185039-89-8 |
详细
|
| PD173955 |
6-(2,6-二氯苯基)-8-甲基-2-[[3-(甲硫基)苯基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮 |
260415-63-2 |
详细
|
| GlyH-101 |
GLYH 101 |
328541-79-3 |
详细
|
| BMS-687453 |
BMS 687453 |
1000998-59-3 |
详细
|
| Dynasore |
DYNASORE |
304448-55-3 |
详细
|
| GKT137831 |
2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮 |
1218942-37-0 |
详细
|
| Fatostatin A |
FATOSTATIN A |
125256-00-0 |
详细
|
| TH 5487 |
TH 5487 |
2304947-71-3 |
详细
|
| BO-264 |
BO-264 |
2408648-20-2 |
详细
|
| NS-3-008 |
NS-3-008（HCl） |
1172854-54-4 |
详细
|
| MAC-545496 |
MAC-545496 |
838810-96-1 |
详细
|
| ML-109 |
ML-109 |
1186649-91-1 |
详细
|
| ID 8 free base |
1-(4-甲氧基苯基)-2-甲基-3-硝基-1H-吲哚-6-醇 |
147591-46-6 |
详细
|
| KN-93 base or HCI |
(E)-N-(2-(((3-(4-氯苯基)烯丙基)(甲基)氨基)甲基)苯基)-N-(2-羟乙基)-4-甲氧基苯磺酰胺 |
139298-40-1 |
详细
|
| MHY1485 |
MHY1485 |
326914-06-1 |
详细
|
| FRAX486 |
FRAX486 |
1232030-35-1 |
详细
|
| AM-0902 |
AM0902 |
1883711-97-4 |
详细
|
| Hydroxy-Dynasore |
DYNGO-4A |
1256493-34-1 |
详细
|
| SU-5607 |
IC261游离态 |
186611-52-9 |
详细
|
| SB366791 |
3-(4-氯苯基)-N-(3-甲氧基苯基)-2-丙烯酰胺 |
472981-92-3 |
详细
|
| FG2216 |
BIQ |
223387-75-5 |
详细
|
| ACY-775 |
CS-2821 |
1375466-18-4 |
详细
|
| JAK3-IN-6 |
JAK3-IN-6 |
1443235-95-7 |
详细
|
| Tegobuvir |
5-[[6-[2,4-双(三氟甲基)苯基]-3-哒嗪基]甲基]-2-(2-氟苯基)-5H-咪唑并[4,5-C]吡啶 |
1000787-75-6 |
详细
|
| PF-4878691 |
532959-63-0 |
532959-63-0 |
详细
|
| GSK2801 |
1-(1-(2-(甲磺酰)苯基)-7-丙氧基吲哚嗪-3-基)乙酮 |
1619994-68-1 |
详细
|
| 4-(Chloromethyl)-2,6-dimethylpyridine |
2,6-二甲基-4-氯甲基吡啶 |
120739-87-9 |
详细
|
| Voxtalisib (XL765, SAR245409) |
2-氨基-8-乙基-4-甲基-6-(1H-吡唑-3-基)吡啶并[2,3-d]嘧啶-7(8H)-酮 |
934493-76-2 |
详细
|
| ON1231320 |
CS-2589 |
1312471-39-8 |
详细
|
| Lersivirine(UK 453061) |
3-氰基-5-[[3,5-二乙基-1-(2-羟基乙基)-1H-吡唑-4-基]氧基]苯腈 |
473921-12-9 |
详细
|
| CWHM-12 |
CWHM-12 |
1564286-55-0 |
详细
|
| Voxelotor(GBT440, GTx011) |
沃塞洛托 |
1446321-46-5 |
详细
|
| AMG-3969 |
AMG-3969 |
1361224-53-4 |
详细
|
| Defactinib hydrochloride |
地法替尼盐酸盐 |
1073160-26-5 |
详细
|
| GNE-3511 |
化合物GNE-3511 |
1496581-76-0 |
详细
|
| yGsy2p-IN-1 |
化合物YGSY2P-IN-1 |
2415003-97-1 |
详细
|
| Aripiprazole Dimer Impurity |
阿立哌唑二聚物 |
1797986-18-5 |
详细
|
| GW2580 |
GW2580 |
870483-87-7 |
详细
|
| KN92 phosphate |
KN92 游离和盐酸盐 |
1135280-28-2 |
详细
|
| G007-LK |
G007-LK |
1380672-07-0 |
详细
|
| TYRPHOSTIN AG 528 |
酪氨酸磷酸化抑制剂AG528 |
133550-49-9 |
详细
|
| XMU-MP-1 |
XMU-MP-1 |
2061980-01-4 |
详细
|
| MD2-IN-1 |
MD2-IN-1 |
111797-22-9 |
详细
|
| mTOR inhibitor-1 |
152-53-4 |
468747-17-3 |
详细
|
| SSE15206 |
1370046-40-4 |
1370046-40-4 |
详细
|
| AS1517499 |
AS1517499 |
919486-40-1 |
详细
|
| GLX351322 |
CS-2871 |
835598-94-2 |
详细
|
| SGI 1027 |
SGI-1027 |
1020149-73-8 |
详细
|
| WH-4-023 |
2,6-DIMETHYLPHENYL 2,4-DIMETHOXYPHENYL(2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDIN-4-YL)CARBAMATE |
837422-57-8 |
详细
|
| SI-60 |
(4-羟基苯基)(甲基)(萘-1-基甲基)锍六氟锑酸盐 |
133152-67-7 |
详细
|
| AK120765 |
AK120765 |
955272-06-7 |
详细
|
| PEO-IAA |
2-(1H-吲哚-3-基)-4-氧基-4-苯基亮氨酸 |
6266-66-6 |
详细
|
| TRPM8 antagonist 2 |
TRPM8 拮抗剂 |
259674-19-6 |
详细
|
| Ellipticine hydrochloride |
玫瑰树碱盐酸盐 |
5081-48-1 |
详细
|
| ZM223 |
ZM223;ZM-223;ZM 223 |
2031177-48-5 |
详细
|
| CK869 |
CK-869 |
388592-44-7 |
详细
|
| XMD-17-51 |
XMD-17-51 |
1628614-50-5 |
详细
|
| DMU2139 |
CS-2867 |
104890-70-2 |
详细
|
| XMD 8-92 |
2-[[2-乙氧基-4-(4-羟基-1-哌啶基)苯基]氨基]-5,11-二氢-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 |
1234480-50-2 |
详细
|
| AF64394 |
CS-2866 |
1637300-25-4 |
详细
|
| Seclidemstat |
SECLIDEMSTAT |
1423715-37-0 |
详细
|
| DMU2105 |
CS-2868 |
1031063-36-1 |
详细
|
| AC5216 |
AC-5216 |
226954-04-7 |
详细
|
| CHIR-98014 |
CHIR98014(CT98014) |
252935-94-7 |
详细
|
| metipranolol |
美替洛尔 |
22664-55-7 |
详细
|
| ERK5-IN-2 |
ERK5-IN-2 |
1888305-96-1 |
详细
|
| SJA710-6 |
SJA710 6; SJA710-6; SJA-710-6; SJA 710-6 |
1397255-09-2 |
详细
|
| Datelliptium chloride |
2-[2-(二乙氨基)乙基]-9-羟基-5,11-二甲基-6H-吡啶并[4,3-B]咔唑 |
105118-14-7 |
详细
|
| IDF-11774 |
化合物IDF-11774 |
1429054-28-3 |
详细
|
| SBI-115 |
SBI-115 |
882366-16-7 |
详细
|
| (+/-)-BAY K 8644 |
1,4-二氢-2,6-二甲基-5-硝基-4-(2-三氟甲基苯基)吡啶-3-羧酸甲酯 |
71145-03-4 |
详细
|
| TRi-1 |
TRi-1 |
246020-68-6 |
详细
|
| MRT68921 HCI |
MRT68921 HCl |
2070014-87-6 |
详细
|
| AC 55541 |
(E)-N-(2-(2-(1-(3-溴苯基)亚乙基)肼基)-2-氧代-1-(4-氧代-3,4-二氢邻苯二甲嗪-1-基)乙基)苯甲酰胺 |
916170-19-9 |
详细
|
| MK-4101 |
5-(3,3-二氟环丁基)-3-[4-[4-甲基-5-[2-(三氟甲基)苯基]-4H-1,2,4-三唑-3-基]双环[2.2.2]辛烷-1-基]-1,2,4-恶二唑 |
935273-79-3 |
详细
|
| BAY-876 |
BAY-876 |
1799753-84-6 |
详细
|
| GSK189254A |
6-(3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPIN-7-YLOXY)-N-METHYLNICOTINAMIDE |
720690-73-3 |
详细
|
| PFI-3 |
(2E)-1-(2-羟基苯基)-3-[(1R,4R)-5-(2-吡啶基)-2,5-二氮杂双环[2.2.1]庚-2-基]-2-丙烯-1-酮 |
1819363-80-8 |
详细
|